LCS(Xiamen Encheng Pharma)

N/A

Report date: 2024/12/16 13:40:20

Base Information

Drug NameLCS(Xiamen Encheng Pharma)
Drug Alias NameLCS干混悬剂LCS干混悬剂（改良型新药）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUlcerStomach UlcerDuodenal Ulcer +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXiamen Encheng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Encheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUlcerStomach UlcerDuodenal Ulcer +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A